Surveillance for various injectable antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa in Hyogo Prefecture

Japanese Journal of Antibiotics

Volumn 58, Issue 5, 2005, Pages 458-468

  Koufuku, Tomomi ^a   Okazaki, Tomomi ^b   Hujiwara, Miki ^c   Adati, Masayo ^d   Yamanouti, Sumika ^e   Kanou, Emiko ^f   Nakajima, Yuko ^g   Hayashi, Tsuneo ^h   Kitayama, Shigeo ⁱ   Kinoshita, Shohiro ^j  

^a Hyogo Prefectural Amagasaki Hospital   (Japan)

^b Kobe College   (Japan)

^c Hyogo Clinical Laboratory   (Japan)

^d Akashi Municipal Hospital   (Japan)

^e Kawasaki Hospital   (Japan)

^f Hyogo Prefectural Nishinomiya Hospital   (Japan)

^g KANSAI ROSAI HOSPITAL   (Japan)

^h Yoka Hospital   (Japan)

ⁱ Kobe Red Cross Hospital   (Japan)

^j KOBE UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOZOPRAN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; MULTIDRUG RESISTANCE PROTEIN; PANIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG SURVEILLANCE PROGRAM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION;

ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INJECTIONS; JAPAN; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEROTYPING;

EID: 28244443332     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. HIRAKATA, Y.,T.YAMAGUCHI, M. NAKANO, et al.: Clinical and bacteriological characteristics of IPM-type metallobeta-lactamase-producing Pseudomonas aeruginosa. Clin. Infect. Dis. 37: 26-32, 2003
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement, Vol. 24, no. 1. MlOO-S 14. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, 2004
3. Chemotherapy 38: 182-189, 1993
4. ARAKAWA, Y.; N. SHIBATA, K. SHIBAYAMA, et al.: Conve-nient test for screening metallo-β-lactamase-produsing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38: 40-43, 2000
5. TSUJI, A.; I. KOBAYASHI, T. OGURI, et al: An epidemiological study of the susdeptibility and frequency of mul-tiple-drug-resistant strains of Pseudomonas aeruginosa isolated medical institutes nationwide in Japan. J. Infect. Chemother. 11: 64-70, 2005
6. SATAKE, S.; E. YOSHIHARA & T. NAKAE: Diffusion of -lactam antibiotics through liposome membranes reconsti-tuted from purified porins of the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34: 685-690, 1990
7. LI, X. Z.; H. NIKAIDO & K. POOLE: Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 1948-1953, 1995
8. NISHIO, H.; M. KOMATSU, N. SHIBATA, et al.: Metallo-β-lactamase- producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical labora-tories in the Kinki region of Japan. J. Clin. Microbiol. 42(11): 5256-5263, 2004